5G is not a single technology — it's a collection of frequency bands with very different physical properties and biological interaction profiles. The most novel — and least studied — is the millimeter wave (mmWave) band above 24 GHz. Here's what researchers know, what they're watching, and how the Aires resonator has been tested at 5G frequencies.
The Three 5G Frequency Bands
5G networks operate across three spectrum tiers:
- Low-band (sub-1 GHz): 600–900 MHz. Long range, deep tissue penetration, but limited data capacity. Similar frequencies to 4G LTE. This band has the most extensive historical safety research.
- Mid-band (1–6 GHz, FR1): The primary deployment band for 5G in most markets. Includes the popular 3.5 GHz (n77/n78) band and the newly auctioned 6 GHz upper band. Overlaps with existing Wi-Fi 6E spectrum.
- High-band / mmWave (24–100 GHz, FR2): Very short range (10–50 meters), very high data density. Deployed in dense urban environments, stadiums, and transportation hubs. These frequencies are physically distinct from lower bands — they're absorbed primarily at the skin surface and in the eye rather than penetrating deeper tissue.
Why mmWave Is a New Research Frontier
The biological safety research base for frequencies above 6 GHz is thin relative to the extensive 900 MHz–2.4 GHz literature built up over 30 years of mobile phone research. The International Agency for Research on Cancer (IARC) Group 2B classification for RF-EMF is based primarily on evidence from lower-frequency bands; mmWave frequencies have not been fully evaluated.
What makes mmWave biologically distinct:
- Penetration depth is approximately 1–2 mm (skin surface and eye) vs. centimeters for lower frequencies
- Energy is absorbed in a thin surface layer, raising different questions about skin and eye exposure
- The interaction of mmWave with skin may affect sweat duct resonances, a topic of active research
- Higher power density at close range in dense urban deployments
How the Aires Resonator Has Been Tested at 5G Frequencies
The Aires technology has been independently validated across the 5G frequency spectrum through engineering studies:
- C20S5G R&D Report (Aires Crystal, 2019): Engineering testing at 6 GHz (upper FR1, 5G) and 28 GHz (FR2, mmWave). Confirmed resonator response in both 5G frequency bands.
- 64P1S5G R&D Report (2020): MEMS simulation of the 64P1S resonator matrix (used in Lifetune ZONE and ZONE MAX) at 28 GHz. Confirmed characteristic resonant response at 5G mmWave frequencies.
- Springer simulation (Lukyanov et al., 2022): Computer simulation of the Lifetune resonator across the relevant EMF frequency range, published in Springer proceedings.
- ITMS 2018: Physical study of fractal structure interactions with GHz electromagnetic waves including millimeter wave range.
The granted US Patent (US12239835B2) explicitly claims coverage from 2.4 GHz to 28 GHz — the full range of current Wi-Fi through 5G mmWave deployment.
The Research Gap and What It Means
The honest answer on 5G mmWave health effects is that the research base is thin. Most published biological effects research uses EMF sources in the 900 MHz–2.4 GHz range. The 2025 IFRAN study (Pavlov Institute) used a Wi-Fi 6 router at 6 GHz — the first Aires biological study to use a 5G-era frequency source — and found genotype-dependent blood parameter changes normalized by Lifetune ZONE MAX.
The engineering validation at 28 GHz demonstrates that the resonator functions at mmWave frequencies. Whether the biological normalization effects documented at lower frequencies extend to mmWave is a question that future research will need to address.